BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Information Letter on Erwinase® 10.000 IU/vial, powder for solution for injection: information on temporary shortage

Active substance: crisantaspase

The company Jazz Pharmaceuticals Germany GmbH is circulating information on the fact that, due to a temporary shortage, Erwinase® 10.000 I.U./vial powder for solution for injection is currently only available under consideration of the provisions of Section 73 (3) AMG.

Download DHPC / Information letter , Download_VeroeffentlichtAm_EN PDF, 261KB, File is accessible

Use of cookies

Cookies help us to provide our services. By using our website you agree that we can use cookies. Read more about our Privacy Policy and visit the following link: Privacy Policy (only in German)

OK